Linda Black
CEO at Gallant Therapeutics
Dr Linda Black, DVM, PhD, has been CEO of Gallant Therapeutics since April 2021. With deep experience in veterinary stem cell therapies, she led the development of groundbreaking “off-the-shelf” stem cell treatments for dogs. Linda holds a DVM and a PhD in cell and molecular biology and has completed a post-doctoral fellowship at GlaxoSmithKline.
All articles by Linda Black
Have you heard about our
Membership?
The number one resource for veterinary professionals.
From hundreds of CPD courses to clinical skills videos. There is something for everyone.
Discover more